Published in Arch Neurol on May 01, 2006
Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology (2009) 1.59
The role of zinc in cerebral ischemia. Mol Med (2007) 1.05
Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J Pharmacol Exp Ther (2009) 1.02
Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence. J Cereb Blood Flow Metab (2010) 1.01
Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol (2012) 0.99
Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke (2011) 0.94
Camera in the emergency department: the evolution of stroke telemedicine. Mayo Clin Proc (2009) 0.90
Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network. J Stroke Cerebrovasc Dis (2011) 0.89
Imaging of acute ischemic stroke. Neuroimaging Clin N Am (2010) 0.89
Advances in stroke therapy. Drug Deliv Transl Res (2011) 0.88
Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain (2009) 0.87
TRPM7 in cerebral ischemia and potential target for drug development in stroke. Acta Pharmacol Sin (2011) 0.83
Safety of thrombolysis in patients over the age of 80. Neurologist (2012) 0.82
Early and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke system. Pak J Med Sci (2013) 0.82
Safety of protocol violations in acute stroke tPA administration. J Stroke Cerebrovasc Dis (2013) 0.82
Stroke imaging research road map. Neuroimaging Clin N Am (2011) 0.82
The effects of telemedicine on racial and ethnic disparities in access to acute stroke care. J Telemed Telecare (2015) 0.81
Hip Hop Stroke: Study Protocol for a Randomized Controlled Trial to Address Stroke Literacy. J Clin Trials (2015) 0.81
Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal. J Neurosci Rural Pract (2016) 0.79
Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset. Neuroradiology (2013) 0.79
Nursing Roles within a Stroke Telemedicine Network. J Cent Nerv Syst Dis (2010) 0.78
Neuroimaging of cerebral ischemia and infarction. Neurotherapeutics (2011) 0.78
Medico-legal aspects of using tissue plasminogen activator in acute ischemic stroke. Curr Treat Options Cardiovasc Med (2011) 0.77
Combination Low-Dose Tissue-Type Plasminogen Activator Plus Annexin A2 for Improving Thrombolytic Stroke Therapy. Front Cell Neurosci (2015) 0.77
Neuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage. Neural Regen Res (2014) 0.76
The Potential Impact of Maintaining a 3-Hour IV Thrombolysis Window: How Many More Patients can we Safely Treat? J Neurol Disord Stroke (2013) 0.76
Neuroproteome changes after ischemia/reperfusion injury and tissue plasminogen activator administration in rats: a quantitative iTRAQ proteomics study. PLoS One (2014) 0.76
Patient refusal of thrombolytic therapy for suspected acute ischemic stroke. Int J Stroke (2012) 0.75
Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt. J Stroke Cerebrovasc Dis (2014) 0.75
Telestroke in an urban setting. Telemed J E Health (2014) 0.75
Nonstroke treatment. Arch Neurol (2006) 0.75
Feasibility of Crosslinked Acrylic Shape Memory Polymer for a Thrombectomy Device. Smart Mater Struct (2014) 0.75
Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time. J Neurol (2014) 0.75
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol (2011) 4.10
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Risk of stroke in children: ethnic and gender disparities. Neurology (2003) 3.47
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol (2008) 3.18
Global variation in the relative burden of stroke and ischemic heart disease. Circulation (2011) 3.02
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke (2007) 2.25
Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med (2008) 2.07
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05
Getting youth in the game: can we accelerate training for clinician-scientists? Ann Neurol (2010) 2.04
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke. Ann Neurol (2012) 1.94
Moyamoya disease in Washington State and California. Neurology (2005) 1.88
Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke (2008) 1.88
Thirty-year projections for deaths from ischemic stroke in the United States. Stroke (2003) 1.86
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke (2011) 1.84
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke (2008) 1.72
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke (2011) 1.72
Translational research for a new administration: what sort of change to believe in? Ann Neurol (2008) 1.71
Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke (2010) 1.71
Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx (2004) 1.71
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ (2009) 1.70
Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke (2012) 1.65
Recruiting subjects for acute stroke trials: a meta-analysis. Stroke (2005) 1.65
Empirical characteristics of litigation involving tissue plasminogen activator and ischemic stroke. Ann Emerg Med (2008) 1.60
Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores. Exp Neurol (2004) 1.58
Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation (2012) 1.58
Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke (2009) 1.56
Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke (2009) 1.56
Neurological disease on the global agenda. Ann Neurol (2008) 1.56
High critical care usage due to pediatric stroke: results of a population-based study. Neurology (2012) 1.56
Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One (2009) 1.55
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke (2007) 1.51
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J (2009) 1.49
The dangers of clinical conviction: an "M&M" of endovascular therapies for stroke. Ann Neurol (2013) 1.48
Why are eligible thrombolysis candidates left untreated? Am J Prev Med (2006) 1.45
Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke (2009) 1.44
4-aminopyridine: new life for an old drug. Ann Neurol (2010) 1.43
Journeys in complex genetics: music and mental illness. Ann Neurol (2009) 1.39
Electronic medical records: does it take a village or a thousand points of light? Ann Neurol (2008) 1.39
That vexing problem of compensation. Ann Neurol (2008) 1.39
Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol (2003) 1.37
A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res (2007) 1.36
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol (2006) 1.33
Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt) (2004) 1.32
Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke (2008) 1.28
Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke (2004) 1.27
A status report on neuroscience research, without grade inflation. Ann Neurol (2006) 1.24
The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke (2012) 1.24
Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery (2005) 1.22
Profiles of lacunar and nonlacunar stroke. Ann Neurol (2011) 1.19
ACCESS: acute cerebrovascular care in emergency stroke systems. Arch Neurol (2010) 1.18
Basic and clinical research: what is the most appropriate weighting in a public investment portfolio? Ann Neurol (2006) 1.18
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke (2009) 1.17
How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke (2008) 1.16
External validation of the ICH score. Neurocrit Care (2004) 1.16
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2012) 1.15
Prevalence and predictors of perinatal hemorrhagic stroke: results from the kaiser pediatric stroke study. Pediatrics (2009) 1.14
The importance of cerebral aneurysms in childhood hemorrhagic stroke: a population-based study. Stroke (2008) 1.13
Cognitive function predicts first-time stroke and heart disease. Neurology (2005) 1.08
Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers. Stroke (2002) 1.07
Epidemiology of intracranial stenosis. J Neuroimaging (2009) 1.07
Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis (2007) 1.05
Safety profile of transcranial near-infrared laser therapy administered in combination with thrombolytic therapy to embolized rabbits. Stroke (2008) 1.05